GE HealthCare Technologies Inc. (GEHC) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

GE HealthCare Technologies Inc. (GEHC) Healthcare & Pipeline Overview

GE HealthCare Technologies Inc. delivers medical technology and digital solutions across imaging, ultrasound, patient care, and pharmaceutical diagnostics. With a global presence and a focus on precision health, GEHC addresses critical needs in diagnosis, treatment, and monitoring, operating with a P/E ratio of 19.7.

What Is the Investment Thesis for GEHC?

GE HealthCare presents a notable research candidate driven by its established market position, diverse product portfolio, and focus on innovation. The company's strong presence in medical imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics provides a stable revenue base with growth potential. With a profit margin of 7.5% and a gross margin of 42.5%, GEHC demonstrates solid profitability. Growth catalysts include the increasing demand for medical imaging and diagnostic services, driven by an aging global population and advancements in medical technology. The company's strategic focus on digital solutions and precision health further enhances its growth prospects. However, investors should be aware of potential risks such as intense competition, regulatory changes, and technological obsolescence. The company's beta of 1.30 indicates higher volatility compared to the market.

Based on FMP financials and quantitative analysis

GEHC Key Highlights

Market capitalization of $33.6B reflects GE HealthCare's significant presence in the medical technology sector.

• P/E ratio of 19.7 suggests a reasonable valuation relative to earnings.
• Gross margin of 42.5% indicates strong pricing power and efficient cost management.
• Dividend yield of 0.22% provides a modest income stream for investors.
• 53,000 employees worldwide demonstrate the company's extensive global operations and reach.

Who Are GEHC's Competitors?

GEHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are GEHC's Key Strengths?

Diversified product portfolio across imaging, ultrasound, patient care, and diagnostics.

• Global presence and established distribution network.
• Strong brand reputation and customer relationships.
• Significant investment in research and development.

What Are GEHC's Weaknesses?

Exposure to regulatory changes and healthcare policy risks.

• Dependence on hospital capital spending budgets.
• Intense competition from other medical technology companies.
• Potential for product recalls or liability claims.

What Could Drive GEHC Stock Higher?

New product launches in medical imaging and digital health solutions.

• Expansion in emerging markets and strategic partnerships.
• Increasing demand for medical imaging and diagnostic services due to aging population.
• Continued investment in research and development to drive innovation.

What Are the Key Risks for GEHC?

Financial-distress signal — its Altman Z-Score of 1.75 sits in the distress zone (elevated bankruptcy risk).

• Regulatory changes and healthcare policy risks.
• Economic downturns and reduced healthcare spending.
• Intense competition from other medical technology companies.
• Cybersecurity threats and data breaches.
• Technological obsolescence and disruption from new entrants.

What Are the Growth Opportunities for GEHC?

• Expansion in Emerging Markets: GE HealthCare can capitalize on the growing demand for healthcare services in emerging markets such as China, India, and Brazil. These regions are experiencing rapid economic growth and increasing healthcare expenditure, creating significant opportunities for GEHC to expand its market presence and increase sales of its medical imaging and diagnostic products.
• Digital Health Solutions: GE HealthCare can leverage its expertise in medical technology to develop and offer innovative digital health solutions. This includes telemedicine platforms, remote patient monitoring systems, and AI-powered diagnostic tools. The digital health market is experiencing rapid growth, driven by the increasing adoption of telehealth and remote monitoring technologies. GEHC can capitalize on this trend by developing and offering cutting-edge digital health solutions that improve patient outcomes and reduce healthcare costs.
• Strategic Partnerships and Acquisitions: GE HealthCare can pursue strategic partnerships and acquisitions to expand its product portfolio and enter new markets. This includes partnering with other medical technology companies, healthcare providers, and research institutions to develop and commercialize innovative products and services. Acquisitions can also be used to acquire new technologies and capabilities, as well as to expand GEHC's geographic reach. The market for medical technology acquisitions is active, with numerous opportunities for GEHC to acquire complementary businesses and technologies.
• Focus on Precision Health: GE HealthCare can focus on developing and offering precision health solutions that are tailored to the individual needs of patients. This includes using genomic data, medical imaging, and other diagnostic information to develop personalized treatment plans. Precision health is a rapidly growing field, driven by the increasing availability of genomic data and the development of new diagnostic technologies. GEHC can capitalize on this trend by developing and offering precision health solutions that improve patient outcomes and reduce healthcare costs.
• Advancements in Artificial Intelligence (AI): GE HealthCare can integrate AI into its medical imaging and diagnostic products to improve their accuracy and efficiency. AI can be used to automate image analysis, detect anomalies, and provide decision support to healthcare professionals. The use of AI in medical imaging is growing rapidly, driven by the increasing availability of data and the development of new AI algorithms. GEHC can capitalize on this trend by integrating AI into its products and services, improving their value proposition and increasing their adoption.

What Are GEHC's Competitive Advantages?

• Strong brand reputation and established market position.
• Extensive product portfolio and global distribution network.
• Significant investment in research and development.
• Proprietary technology and intellectual property.
• High switching costs for customers due to the complexity and cost of medical equipment.

What Does GEHC Do?

GE HealthCare Technologies Inc., incorporated in 2022 and headquartered in Chicago, Illinois, is a global leader in medical technology, diagnostics, and digital solutions. Spun off from General Electric, the company builds on a legacy of innovation in healthcare. GE HealthCare operates through four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers a range of technologies including molecular imaging, computed tomography (CT), magnetic resonance (MR), image-guided therapy, and X-ray systems, along with specialized products for women's health. The Ultrasound segment provides solutions for screening, diagnosis, and monitoring across various medical fields such as radiology, primary care, women's health, and cardiovascular applications. Patient Care Solutions focuses on providing medical devices, consumables, services, and digital solutions for patient monitoring, anesthesia delivery, respiratory care, diagnostic cardiology, and maternal-infant care. The Pharmaceutical Diagnostics segment develops and supplies diagnostic agents, including contrast media and molecular imaging agents, used in various imaging modalities. GE HealthCare's products and services are utilized in hospitals, clinics, and research institutions worldwide, supporting healthcare professionals in improving patient outcomes and enhancing the efficiency of healthcare delivery. The company's commitment to innovation and digital transformation positions it as a key player in the evolving healthcare landscape.

What Products and Services Does GEHC Offer?

• Develops and manufactures medical imaging equipment such as MRI, CT, and X-ray machines.
• Provides ultrasound systems for various medical applications.
• Offers patient monitoring and respiratory care solutions.
• Supplies diagnostic agents and contrast media for medical imaging.
• Provides digital solutions and software for healthcare providers.
• Offers services and support for its medical equipment.

How Does GEHC Make Money?

• Sells medical imaging equipment, ultrasound systems, and patient care solutions to hospitals, clinics, and other healthcare providers.
• Generates revenue from the sale of diagnostic agents and contrast media.
• Provides service and maintenance contracts for its equipment.
• Offers digital solutions and software subscriptions to healthcare providers.

What Industry Does GEHC Operate In?

GE HealthCare operates in the medical technology and healthcare information services industry, which is experiencing significant growth driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements. The competitive landscape includes major players like A: Agilent Technologies, Inc. and IQV: IQVIA Holdings Inc., as well as specialized companies focusing on specific segments of the market. GE HealthCare's broad product portfolio and global presence position it as a key competitor in this dynamic industry.

Who Are GEHC's Key Customers?

• Hospitals and clinics
• Diagnostic imaging centers
• Research institutions
• Government healthcare agencies

GE HealthCare Technologies Inc. Financial Trajectory

GE HealthCare Technologies Inc. (GEHC) reported $5.29B in revenue for Q2 2026, reflecting 3.2% growth compared to the prior quarter. The company recorded net income of $573.0M, with diluted EPS of $1.26. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, GEHC averaged $0.87 in diluted EPS.

Company Profile

GE HealthCare Technologies Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Chicago, US. The company is led by CEO Peter J. Arduini. GEHC has traded publicly since 2022.

How GE HealthCare Technologies Inc. Is Valued

GE HealthCare Technologies Inc. carries a market capitalization of $33.6B, placing it in the large-cap category. Relative to its peer group, GEHC's quantitative score of 61/100 is below the peer average of 79/100.

Return on equity for GE HealthCare Technologies Inc. stands at 14.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.1%, showing how much profit it generates from its asset base. GEHC trades at a trailing price-to-earnings ratio of 19.66, below the Healthcare sector average of ~23x. Its free cash flow yield is 5.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.

GE HealthCare Technologies Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.75 places it in the distress zone, a signal of elevated financial risk.

GE HealthCare Technologies Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.3% above estimates on average.

Wall Street analysts project GE HealthCare Technologies Inc. revenue of about $21.72B for fiscal 2026, with EPS near $4.92. The estimate reflects 15 contributing analysts.

Over the past six months, GE HealthCare Technologies Inc. insiders filed 15 SEC Form 4 transactions — 2 sales and 13 purchases. On net that is roughly 53K shares acquired (about $358K) — insiders putting money in tends to read as conviction.

GEHC Financials

GEHC Latest News

GEHC Analyst Consensus

GEHC MoonshotScore

Latest GE HealthCare Technologies Inc. Analysis

What Investors Ask About GE HealthCare Technologies Inc. (GEHC) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources